Altana forms joint venture with Bracco:
This article was originally published in Clinica
Executive Summary
Altana's diagnostics subsidiary, Byk Gulden (Germany), has formed a joint venture with Bracco (Italy). Ownership will be 51:49 in favour of Bracco. The joint venture will expand the companies' existing co-operation from Germany and Italy to include France, Benelux, Poland, the Czech Republic and Slovakia. Bracco will develop the contrast agents while Byk Gulden will handle production and marketing and gain access to Bracco's MRI and ultrasound contrast agents products. Altana expects its diagnostics turnover to increase from DM 275 million ($194 million) this year to DM 400 million by the year 2000.